WaveMan · Form 4
Cormorant Global Healthcare Master Fund, LP insider trades
> Search tickers & screens ⌘K
LIVE

Cormorant Global Healthcare Master Fund, LP insider trades

Cormorant Global Healthcare Master Fund, LP has filed 12 Form 4s with the SEC that we hold, for Biomea Fusion, Inc. (BMEA) (Director, 10% owner), EyePoint, Inc. (EYPT) (10% owner), Bright Minds Biosciences INC. (DRUG) (10% owner) and Corbus Pharmaceuticals Holdings, Inc. (CRBP) (10% owner), among 10 companies in all. Across all of them we count 38 purchases worth $81.6M and 11 sales worth $49.7M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 3,390,943 shares of MoonLake Immunotherapeutics worth $25.7M, dated 2025-09-29. The first filing on our record is dated 2021-07-07 and the latest 2025-10-01.

Biomea Fusion, Inc. (BMEA)

Director, 10% owner · 2 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-03-30P, purchase reported on Form 4400,000$12.0M2023-04-03

EyePoint, Inc. (EYPT)

10% owner · 2 filings · 19 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-12-04P, purchase reported on Form 4945,664$18.8M2023-12-06
2023-12-04P, purchase reported on Form 4122,625$2.5M2023-12-06
2023-12-04P, purchase reported on Form 479,805$1.7M2023-12-06
2023-12-04P, purchase reported on Form 428,090$640.5K2023-12-06
2023-12-04P, purchase reported on Form 437,081$890.3K2023-12-06
2023-12-04P, purchase reported on Form 439,899$992.3K2023-12-06
2023-12-04P, purchase reported on Form 465,086$1.7M2023-12-06
2023-12-04P, purchase reported on Form 453,109$1.4M2023-12-06
2023-12-04P, purchase reported on Form 427,425$764.3K2023-12-06
2023-12-04P, purchase reported on Form 48,168$235.1K2023-12-06
2023-12-04P, purchase reported on Form 418,601$556.4K2023-12-06
2023-12-04P, purchase reported on Form 415,582$479.0K2023-12-06
2023-12-04P, purchase reported on Form 486,713$2.8M2023-12-06
2023-12-04P, purchase reported on Form 4321,259$6.0M2023-12-06
2023-12-04P, purchase reported on Form 48,260$284.9K2023-12-06
2023-12-04P, purchase reported on Form 441,824$1.4M2023-12-06
2023-12-04P, purchase reported on Form 419,866$670.5K2023-12-06
2024-04-18P, purchase reported on Form 4186,521$3.5M2024-04-22
2024-04-18P, purchase reported on Form 4395,244$7.0M2024-04-22

Bright Minds Biosciences INC. (DRUG)

10% owner · 1 filing · 11 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-10-15P, purchase reported on Form 42,600$22.9K2024-10-17
2024-10-15P, purchase reported on Form 4238,097$1.1M2024-10-17
2024-10-15P, purchase reported on Form 463,173$374.0K2024-10-17
2024-10-15P, purchase reported on Form 433,343$214.1K2024-10-17
2024-10-15P, purchase reported on Form 48,900$65.1K2024-10-17
2024-10-15P, purchase reported on Form 42,700$25.0K2024-10-17
2024-10-15P, purchase reported on Form 419,169$224.7K2024-10-17
2024-10-15P, purchase reported on Form 44,609$56.9K2024-10-17
2024-10-16P, purchase reported on Form 47,150$171.8K2024-10-17
2024-10-16P, purchase reported on Form 43,107$78.4K2024-10-17
2024-10-16P, purchase reported on Form 439,743$922.8K2024-10-17

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

10% owner · 1 filing · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-09-20P, purchase reported on Form 425,943$476.3K2024-09-24
2024-09-20P, purchase reported on Form 445,085$788.1K2024-09-24
2024-09-20P, purchase reported on Form 425,769$572.8K2024-09-24
2024-09-20P, purchase reported on Form 4139,551$2.8M2024-09-24
2024-09-20P, purchase reported on Form 466,088$1.3M2024-09-24
2024-09-20P, purchase reported on Form 447,564$1.0M2024-09-24

ICVX

Reporting owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Immuneering Corp (IMRX)

10% owner · 1 filing · 5 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-03-14S, sale reported on Form 411,040$65.9K2024-03-18
2024-03-14S, sale reported on Form 454,215$291.1K2024-03-18
2024-03-14S, sale reported on Form 498,570$418.9K2024-03-18
2024-03-14S, sale reported on Form 4345,266$1.1M2024-03-18
2024-03-15S, sale reported on Form 4400,000$856.0K2024-03-18

Jade Biosciences, Inc. (AVTE)

Reporting owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2021-07-02P, purchase reported on Form 4500,000$7.0M2021-07-07

MoonLake Immunotherapeutics (MLTX)

Reporting owner · 1 filing · 5 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-09-29S, sale reported on Form 4232,460$2.0M2025-10-01
2025-09-29S, sale reported on Form 470,748$663.6K2025-10-01
2025-09-29S, sale reported on Form 43,390,943$25.7M2025-10-01
2025-09-29S, sale reported on Form 42,800,000$18.5M2025-10-01
2025-09-30S, sale reported on Form 45,827$40.6K2025-10-01

OnKure Therapeutics, Inc. (OKUR)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2025-05-12S, sale reported on Form 424,300$48.4K2025-05-14

VIGL

Reporting owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1618442) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms